share_log

【天相投资】天药股份:主要产品平稳增长,新厂通过GMP认证

天相投資 ·  Feb 16, 2012 00:00  · Researches

Profit forecasts and ratings. The company's 2012 and 2013 EPS are expected to be 0.22 yuan and 0.29 yuan respectively. According to the latest closing price calculation, the corresponding dynamic price-earnings ratios are 29 times and 21 times, respectively. The company has advanced production technology, and its market share is expected to continue to rise, consolidating its leading position. Maintain an investment rating of “excess holdings.” Risk warning: 1) The price of raw materials fluctuates greatly; the price of products fluctuates greatly. 2) RMB appreciation and changes in export policies.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment